Nephros (FRA:NPJP) Accounts Payable & Accrued Expense : €1.07 Mil (As of Mar. 2025)

View and export this data going back to 2023. Start your Free Trial

What is Nephros Accounts Payable & Accrued Expense?

Nephros's quarterly accounts payable & accrued expense increased from Sep. 2024 (€0.65 Mil) to Dec. 2024 (€1.16 Mil) but then declined from Dec. 2024 (€1.16 Mil) to Mar. 2025 (€1.07 Mil).

Nephros's annual accounts payable & accrued expense increased from Dec. 2022 (€0.97 Mil) to Dec. 2023 (€1.53 Mil) but then declined from Dec. 2023 (€1.53 Mil) to Dec. 2024 (€1.16 Mil).

Nephros Accounts Payable & Accrued Expense Historical Data

The historical data trend for Nephros's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nephros Accounts Payable & Accrued Expense Chart

Nephros Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

0.63

1.57

0.97

1.53

1.16

Nephros Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															1.41	1.48	0.65	1.16	1.07

Nephros Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Nephros Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nephros Inc (FRA:NPJP) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

NEPH:USA

Address

380 Lackawanna Place, South Orange, NJ, USA, 07079

Website

https://www.nephros.com

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of its revenue from product sales and a small amount from royalty revenue and other revenues.

Nephros Headlines

No Headlines